ClinicalTrials.gov
public full text
Public Domain
The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo
A national, prospective single arm phase II study investigating the pharmacokinetics and safety of the 2% TD1414 cream when applied 3 times daily for 7 days to adult patients with impetigo or Secondarily Infected Traumatic Lesions (SITL). A total of 20 patients will be enrolled.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Three Times Daily Dosing of UT-15C#885713
- Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers#832397
- Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects#803751
- Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease#838882
- Combined IV and Topical TXA in Major Spine Surgery#884370
Record · ID 1059090
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive